FIELD: food industry; biotechnology.
SUBSTANCE: invention relates to the food industry and biotechnology and is a sweetener composition comprising glycosylated rebaudioside A, glycosylated stevioside and glycosylated rebaudioside C, as well as a composition for preparing a sweetener, a method for preparing the sweetener using a by-product of steviol glycoside and a method for improving the quality of sweetness.
EFFECT: invention enables to obtain a sweetener composition with excellent quality of sweetness; it can be used to manufacture products with high added value, such as food products and fodders.
12 cl, 2 dwg, 6 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| RECOMBINANT PRODUCTION OF STEVIOL GLYCOSIDES | 2014 |
|
RU2741103C2 |
| BIOSYNTHETIC PRODUCTION OF STEVIOL GLYCOSIDE REBAUDIOSIDE D4 FROM REBAUDIOSIDE E | 2017 |
|
RU2764803C2 |
| HYDROLYSIS OF STEVIOL GLYCOSIDES BY BETA-GLUCOSIDASE | 2018 |
|
RU2775697C2 |
| ABC TRANSPORTERS FOR HIGHLY EFFICIENT PRODUCTION OF REBAUDIOSIDES | 2020 |
|
RU2795855C2 |
| POLYPEPTIDES MODULATING SIGLEC-DEPENDENT IMMUNE RESPONSES | 2017 |
|
RU2776807C2 |
| ANTIBODIES TO MUC16 AND THEIR APPLICATION | 2016 |
|
RU2758113C2 |
| GLYCOSYLATED FUSED PROTEINS VWF WITH IMPROVED PHARMACOKINETICS | 2017 |
|
RU2782212C2 |
| PHARMACEUTICAL COMPOSITION, INCLUDING A PH20 VARIANT OF HUMAN HYALURONIDASE, AND A MEDICINAL PRODUCT FOR SUBCUTANEOUS ADMINISTRATION | 2020 |
|
RU2810952C2 |
| NEW VERSIONS OF HYALURONIDASE WITH IMPROVED STABILITY AND THE PHARMACEUTICAL COMPOSITION CONTAINING THEM | 2021 |
|
RU2811464C2 |
| THROMBOLYTICS FOR INTRAVASCULAR THROMBI | 2020 |
|
RU2822136C1 |
